$PBYI
PUMA BIOTECHNOLOGY INC
XNAS•Health Care•Pharmaceutical Preparations
$9.81
▲+3.26%+$0.310
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePUMA BIOTECHNOLOGY INC
XNAS•Health Care•Pharmaceutical Preparations
Why is PBYI up today? It is at $9.81 (+3.26%), and our scanner flagged it 20 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PBYI spikes, and full due diligence on PBYI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PBYI 20 times in the last 30 days. Create a free account to track $PBYI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PBYI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PBYI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystPUMA BIOTECHNOLOGY, INC.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13D/AActivist 5%+ stake updatedOct 7, 2026 · todaySources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cesano Alessandra Director | Sold (automatic/other) | -62K 0.1% of company | sold 52% | 57K | $567K at $9.12 | Sep 14, 26 |
Cesano Alessandra Director | Other | 50K 0.10% of company | added 73% | 119K | $147K at $2.93 | Sep 14, 26 |
Wilson Troy Edward Director | Sold (automatic/other) | -5K | sold 8.4% | 55K | $46K at $9.10 | Sep 14, 26 |
Nougues Maximo F Officer | Sold (automatic/other) | -9K 0.02% of company | sold 3.9% | 231K | $78K at $8.26 | Jul 6, 26 |
Hunt Douglas M Officer | Sold (automatic/other) | -8K 0.02% of company | sold 4.1% | 197K | $70K at $8.26 | Jul 6, 26 |
Auerbach Alan H Officer | Sold (automatic/other) | -44K 0.09% of company | sold 0.6% | 7.26M | $364K at $8.26 | Jul 6, 26 |
Dorval Allison Director | Sold (automatic/other) | -12K 0.02% of company | sold 11% | 91K | $84K at $7.20 | Jun 12, 26 |
Moyes Jay M Director | Sold (automatic/other) | -22K 0.04% of company | sold 27% | 58K | $159K at $7.22 | Jun 12, 26 |
Senderowicz Adrian Director | Sold (automatic/other) | -27K 0.05% of company | sold 50% | 27K | $194K at $7.20 | Jun 12, 26 |
Stuglik Brian M Director | Sold (automatic/other) | -8K 0.02% of company | sold 6.6% | 114K | $58K at $7.20 | Jun 12, 26 |
Wilson Troy Edward Director | Sold (automatic/other) | -11K 0.02% of company | sold 15% | 60K | $78K at $7.20 | Jun 12, 26 |
Cesano Alessandra Director | Acquired (grant/award) | +27K 0.05% of company | added 65% | 69K | n/a | Jun 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PBYI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PBYI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PBYI last traded at $9.81, up 3.26% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
PUMA BIOTECHNOLOGY INC (PBYI) is next expected to report earnings on Thursday, November 5, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PBYI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PBYI 20 times in the last 30 days.
PBYI (PUMA BIOTECHNOLOGY INC) trades on XNAS, with a market cap of about $490M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PBYI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PBYI discussion
Sign in to ask a question or join the discussion.